The authors also demonstrate that the insulin-producing cells of corrected patient hiPSCs protect mice from diabetes, providing a proof-of-principle study for the use of replacement therapy as a treatment for monogenic diabetes. The gene discussed is INS; the disease is diabetes mellitus.